| 20 Nov, 04:39 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 20 Nov, 04:35 pm | — | … | Natco Pharma Limited has informed the Exchange about Transcript | nse |
| 15 Nov, 12:09 pm | — | … | Natco Pharma Limited has informed the Exchange about Link of Recording | nse |
| 15 Nov, 11:50 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 14 Nov, 03:10 pm | — | … | Natco Pharma Limited has informed the Exchange about Presentation | nse |
| 14 Nov, 03:07 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 14 Nov, 01:46 pm | — | … | Natco Pharma Ltd - 524816 - Corporate Action-Board approves Dividend | bse |
| 14 Nov, 01:44 pm | — | … | Natco Pharma Ltd - 524816 - Financial Results For The Quarter And Half Year Ended 30Th September, 2025 | bse |
| 14 Nov, 01:33 pm | — | … | Natco Pharma Limited has informed the Exchange that Record date for the purpose of 2nd Interim Dividend for the FY 2025-26 is 20-Nov-2025. | nse |
| 14 Nov, 01:27 pm | — | … | outcome of Board Meeting held on 14th November, 2025 | nse |
| 12 Nov, 03:07 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Nov, 03:02 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Adcock Ingram Holdings Limited completes delisting from Johannesburg Stock Exchange and NATCO Pharma Limited acquires 35.75% stake". | nse |
| 11 Nov, 12:50 pm | — | … | Natco Pharma Limited has informed the Exchange about Revised intimation earnings call for the quarter and half year ended 30th September, 2025 | nse |
| 07 Nov, 12:26 pm | — | … | Natco Pharma Limited has informed the Exchange about Earnings Call to discuss Q2FY26 Un-audited Financial Results | nse |
| 07 Nov, 11:48 am | — | … | Natco Pharma Ltd - 524816 - Board Meeting Intimation for Considering And Approve The Financial Results For The Period Ended September 30, 2025 And 2Nd Interim Dividend For The Financial Year Ending 2025-26 | bse |
| 31 Oct, 09:07 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 31 Oct, 09:02 am | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)". | nse |
| 17 Oct, 05:11 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Oct, 05:08 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated October 17, 2025, titled "Legal update regarding Risdiplam ". | nse |
| 10 Oct, 01:09 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Oct, 01:07 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated October 10, 2025, titled "Updates on proposed acquisition of shares in Adcock Ingram Holdings Limited". | nse |
| 09 Oct, 05:36 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Oct, 05:32 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated October 09, 2025, titled "Legal update regarding Risdiplam Commercial Appellate Division of the Hon ble Delhi High Court Dismissed Appeal ". | nse |
| 09 Oct, 04:45 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 09 Oct, 04:40 pm | — | … | Natco Pharma Limited has informed the Exchange regarding Appointment of Mr. G. Vijay Kiran Kumar as Vice President Corporate Quality Assurance (Formulations) of the company w.e.f. October 09, 2025. | nse |
| 03 Oct, 09:56 am | — | … | Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 30 Sept, 05:32 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 30 Sept, 05:28 pm | — | … | Natco Pharma Limited has informed the Exchange regarding Cessation of Mr Dr. Santhan Gopalakrishnan Vaidyanathan as Other of the company w.e.f. September 30, 2025. | nse |
| 25 Sept, 10:54 am | — | … | Natco Pharma Limited has informed the Exchange about General Updates | nse |
| 25 Sept, 10:47 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Meeting Updates | bse |
| 19 Sept, 10:53 am | — | … | Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 18 Sept, 09:50 am | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated September 18, 2025, titled "NATCO's Pharma division located in Kothur, Hyderabad, India has now received Establishment Inspection Report (EIR) classifying the facility as "Voluntary Action Indicated (VAI)" from the U.S. Food and Drug Administration (FDA) | nse |
| 18 Sept, 09:49 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 Sept, 05:50 pm | — | … | Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 10 Sept, 11:23 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Sept, 11:19 am | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated September 10, 2025, titled "Update". | nse |